Enzyvant Therapeutics Holdings Limited LONDON


Founded in 2016, Enzyvant Therapeutics Holdings, classified under reg no. 10317630 is an active company. Currently registered at 7th Floor SW1H 0DB, London the company has been in the business for 8 years. Its financial year was closed on March 31 and its latest financial statement was filed on Thu, 31st Mar 2022. Since Tue, 29th Aug 2017 Enzyvant Therapeutics Holdings Limited is no longer carrying the name Enzyvant Therapeutics Holding.

The firm has 2 directors, namely Emma P., Jason R.. Of them, Jason R. has been with the company the longest, being appointed on 28 September 2017 and Emma P. has been with the company for the least time - from 6 October 2023. As of 28 March 2024, there were 4 ex directors - Mark C., Sunil M. and others listed below. There were no ex secretaries.

Enzyvant Therapeutics Holdings Limited Address / Contact

Office Address 7th Floor
Office Address2 50 Broadway
Town London
Post code SW1H 0DB
Country of origin United Kingdom

Company Information / Profile

Registration Number 10317630
Date of Incorporation Mon, 8th Aug 2016
Industry Non-trading company
End of financial Year 31st March
Company age 8 years old
Account next due date Sun, 31st Dec 2023 (88 days after)
Account last made up date Thu, 31st Mar 2022
Next confirmation statement due date Thu, 22nd Aug 2024 (2024-08-22)
Last confirmation statement dated Tue, 8th Aug 2023

Company staff

Emma P.

Position: Director

Appointed: 06 October 2023

Vistra Cosec Limited

Position: Corporate Secretary

Appointed: 28 September 2017

Jason R.

Position: Director

Appointed: 28 September 2017

Mark C.

Position: Director

Appointed: 05 August 2022

Resigned: 06 October 2023

Sunil M.

Position: Director

Appointed: 16 August 2019

Resigned: 05 August 2022

Reuben A.

Position: Director

Appointed: 30 January 2018

Resigned: 16 August 2019

Vant Director Services Limited

Position: Corporate Director

Appointed: 28 September 2017

Resigned: 30 January 2018

Marianne R.

Position: Director

Appointed: 08 August 2016

Resigned: 28 September 2017

Vistra Company Secretaries Limited

Position: Corporate Secretary

Appointed: 08 August 2016

Resigned: 28 September 2017

People with significant control

The list of persons with significant control that own or control the company includes 1 name. As BizStats established, there is Sumitomo Pharma Co., Ltd. from Osaka,541-0045, Japan. This PSC is categorised as "a kabushiki kaisha", has 75,01-100% voting rights and has 75,01-100% shares. This PSC has 75,01-100% voting rights and has 75,01-100% shares.

Sumitomo Pharma Co., Ltd.

6-8, Doshomachi 2-Chome Chuo-Ku, Osaka,541-0045, Osaka, Japan

Legal authority Japan
Legal form Kabushiki Kaisha
Country registered Japan
Place registered Japan
Registration number 3120001077477
Notified on 27 December 2019
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Company previous names

Enzyvant Therapeutics Holding August 29, 2017
Orphavant Holdings January 30, 2017

Company filings

Filing category
Accounts Address Capital Confirmation statement Incorporation Insolvency Officers Persons with significant control Resolution
Small company accounts made up to Fri, 31st Mar 2023
filed on: 30th, December 2023
Free Download (18 pages)

Company search